We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Hormone Found that Decreases Appetite

By Biotechdaily staff writers
Posted on 16 Aug 2002
A study has found that the infusion of a peptide known as PYY3-36 made subjects fell full, which significantly decreased their appetites and their food intake. More...
The study was published in the August 7, 2002, issue of Nature.

The peptide is normally released from the gastrointestinal tract after eating, in proportion to the meal's caloric content. When the subjects in the study received artificial infusions of the hormone at normal post-feeding concentrations, their food intake was reduced by a third for one day. They also reported up to a 40% reduction in perceived levels of hunger over a period of 12 hours after the infusion.

"The discovery that PYY3-36 suppresses appetite could be of huge benefit to those who struggle with weight problems. It may be possible to create a tablet with a similar effect, providing an excellent, natural, and safe long-term treatment for obesity,” said Prof. Stephen Bloom, from Imperial College London (UK), one of the researchers.

Other researchers who participated in the study were from the Oregon Health and Sciences University (Portland, OR, USA) and the Garvan Institute of Medical Research (Sydney, Australia).




Related Links:
Imperial College London

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.